Quetmolimab: A Deep Dive into KANAb 001 and E-6011 The molecule, E-6011, shows a new treatment aimed at the PD-1 receptor. Initial medical data from the two studies, KANAb 001 and E-6011, reveal positive activity in https://www.targetmol.com/compound/quetmolimab